This study is testing the safety of a new medicine, Fostemsavir (FTR), for kids and teens aged 6 to 17 with HIV-1. HIV-1 is a virus that attacks the immune system. These kids are already on other HIV medicines, but those aren't working well anymore. In this study, Fostemsavir is given along with other medicines (OBT) to see how well it works and how the kids' bodies handle it. The researchers will also see if children find the medicine easy to swallow.
Key Points:
- The study involves children and teens aged 6 to under 18 years, weighing at least 20 kg, with HIV-1 resistance to other medicines.
- Participants must be able to swallow pills and attend study visits.
- Girls who have started puberty must not be pregnant and must agree to use birth control if they are sexually active.
Children can't join if they have certain health issues, like liver problems or are taking other restricted medicines. This study is important to find better treatments for young people with HIV-1.
How understandable was the trial content above?
Hard to understand
Easy to understand